Obstetrics & Gynecology

New and Noteworthy

New and Noteworthy

Learn about our faculty and trainees who have recently been recognized for excellence in clinical care, research, teaching and leadership. 

Global Health Spotlight 

As part of the CREW (Cookies, Relationships, Education, and Wellbeing) Project funded by the David Geffen School of Medicine at UCLA, faculty from UCLA partnered with the University of Venda in South Africa to co-develop a curriculum focused on sexual health, mental health, and relationship wellbeing for college students. Led by Drs. Lisa Nicholas and Michelle Cooley-Strickland, the team collaborated with local professors and psychologists in Limpopo and visited Chris Hani Baragwanath Hospital in Johannesburg to learn from maternal mental health providers and tour the OB/GYN facilities. 

Honors, Awards, Appointments and Grants 

Brittany Burton, MD (OB Anesthesiology), was awarded the 2025 SOAP/FAER Mentored Research Training Grant at the SOAP Annual Meeting for her proposal on “Determinants of Health and Machine Learning for Healthcare Utilization in Obstetric Care.” This project is co-mentored by Dr. Keith Norris, Dr. Christina Han and Dr. Maxime Cannesson.    

Karenee Demery, MD (OVMC) was nominated by the David Geffen School of Medicine at UCLA to the AAMC’s Minority Faculty Leadership Development Seminar to be held at the AAMC Learning Center in Washington, DC in June 2025. This program provides participants with real-world guidance and tools for pursuing career advancement in academic medicine. Participants will develop key professional competencies that build skills in grant writing and communications, while expanding their network of colleagues and role models.   

Audra Fain, MD (PGY-3) has been honored with the 2025 DGSOM Excellence in Teaching with Humanism Award. 

Beth Y. Karlan, MD, has joined Sharsheret’s Medical Advisory Board. As a leader in cancer research, Dr. Karlan’s work in early detection, precision prevention, and personalized treatment will help strengthen Sharsheret’s support for women, men and families facing breast cancer and ovarian cancer. Sharsheret, Hebrew for chain, is the only national organization supporting Jewish women and families, of all backgrounds, facing breast and ovarian cancer—those who are diagnosed and those at high risk. 

Erica Oberman, MD, was selected to participate in the 2025 DGSOM-Anderson Program for Leadership in Academic Medicine.  

Erica Oberman MD, is the recipient of the UCLA Serge & Yvette Dadone Clinical Teaching Award.    

Aparna Sridhar, MD MPH, was awarded the DGSOM Global Health Collaboration Award which supports a bilateral Clinical and Educational Exchange in Obstetrics and Gynecology between UCLA and Narendra Modi Medical College, India, demonstrating a strong commitment to global health collaboration and capacity building.  

Aparna Sridhar, MD MPH, is the recipient of the David Geffen School of Medicine at UCLA Kaiser-Permanente Award for Excellence in Teaching.  

Aparna Sridhar, MD, MPH, was awarded a 2025-2026 DGSOM Global Health Seed Grant for her proposal, “Optimizing Maternal Outcomes: Adapting Quantitative Blood Loss Measurement in Routine Maternity Care.” This project addresses postpartum hemorrhage (PPH), the leading cause of maternal mortality globally, by implementing quantitative blood loss (QBL) measurement to replace inaccurate visual estimation methods. 

Halina Yee, MD (PGY-6), family planning fellow, is a recipient of the Society of Family Planning’s 2025 Uta Landy Complex Family Planning Scholars award for her proposal on understanding endometrial responses to GLP-1 agonist use. 

Molly Zielenbach, MD (OVMC) has been selected to serve as a David Geffen School of Medicine at UCLA HEALS Thread Facilitator for this current and upcoming academic year. As such, she will join a select group of exceptional educators who will facilitate small group sessions during the HEALS Curriculum on topics related to ethics, humanities, structural racism and health equity, as well as facilitate reflection sessions for the Early Authentic Clinical Experience (EACE) to help guide our students in their professional growth.  

Misty Richards, MD, MS, was awarded $50,000 by the UCLA Ronald Reagan Medical Center Board of Advisors Strategic Fund for the MOMS Clinic team's outstanding work.  

Presentations 

At the 2025 ACOG Annual Clinical & Scientific Meeting, UCLA’s Department of Obstetrics and Gynecology showcased significant contributions across various sessions.  

  • Rajita Patil, MD, director of UCLA Health’s Comprehensive Menopause Care program, led a pre-congress workshop introducing both foundational and advanced courses on menopause management. Her initiative reflects UCLA’s commitment to enhancing menopause care through multidisciplinary collaboration and innovative assessment tools.  
  • Neil Silverman, MD, a clinical professor specializing in obstetric infectious diseases, provided updates on maternal RSV vaccination, emphasizing the latest developments for the 2024–2025 respiratory season.  
  • Aparna Sridhar, MD, clinical professor, moderated the esteemed Howard Taylor International Symposium, which addressed global challenges in women’s health.  
  • Brittany Bergam, MD, a PGY3 resident, served as the resident reporter for California, contributing to the dissemination of key insights from the conference.  

Daniel Nassar, MPH, DO, MIGS fellow, presented his video on diaphragm endometriosis excision at the 2025 Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Meeting. 

An REI fellow and two residents presented abstracts at the recent Pacific Coast Reproductive Society (PCRS) Annual Meeting. 

  • Esther Wu, MD, OBGYN resident: Investigating the Association Between Clinic Volume and Pre-Implantation Genetic Testing (Pgt) Utilization in US-based Assisted Reproductive Technology (Art) Programs. 
  • Mabel Lee, MD, REI fellow: Oocyte Warming Outcomes and Live Birth Rates Over a 5 to 7 Year Follow Up Period After Planned Oocyte Cryopreservation Cycles. 
  • Anais Stepanian, MD, OBGYN resident: Needle phobia in Patients Pursuing IVF: How Big of an Issue is it? 

Mya Zapata, MD, presented to the UCLA Health Ronald Reagan Clinical Excellence Committee (CEC) on the quality work being done by the Department of Obstetrics and Gynecology to improve patient care, quality, and safety.  

Publications 

  • Ligumsky LK, Desmond A, Kirschner V, Martinez G, Newens J, Satou G, Calkins K, Afshar Y. Standardized clinical assessment and management plan enhances neonatal outcomes in prenatally diagnosed congenital heart disease. Pediatr Cardiol. 2025 Jun 14. doi:10.1007/s00246-025-03923-4. PMID: 40517188.  
  • Fortes PA, Janzen C, Lei MYY, Vangala S, Sung K, Devaskar SU, Sullivan PS. Does Amsterdam criteria applied to largely unsubmitted term placentas with favorable fetal outcomes show significant maternal clinicopathologic correlation? Am J Clin Pathol. 2025 May 17;163(5):688-695. doi:10.1093/ajcp/aqae174. PMID: 39761233; PMCID: PMC12086057.  
  • Sarsam J, Desmond A, Roustaei M, Satou G, Afshar Y. A novel prenatal pipeline for three-dimensional hemodynamic modeling of the fetal aorta. J Ultrasound Med. 2025 May 28. doi:10.1002/jum.16721. PMID: 40434286.  
  • Shafrir AL, Laliberte A, Wallace B, Vitonis AF, Sieberg CB, Ghiasi M, Magpantay LI, Epeldegui M, Schrepf A, As-Sanie S, Terry KL, Missmer SA. Pelvic Pain Symptoms and Inflammation Among Adolescents and Adults with and Without Endometriosis. Int J Mol Sci. 2025 Jun 4;26(11):5377. doi: 10.3390/ijms26115377. PMID: 40508188; PMCID: PMC12156163.  
  • Karlan BY, et al. Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis. Gynecol Oncol. 2025 Jun 5;198:112-129. doi: 10.1016/j.ygyno.2025.05.013. Epub ahead of print. PMID: 40482607.  
  • Abbott DH, Dumesic DA. Monoclonal antibody therapy for PCOS? Cell Metab. 2025 Jun 3;37(6):1247-1249. doi: 10.1016/j.cmet.2025.05.002. PMID: 40466621.  
  • Devabhaktuni A, Han CS. Thyroid disease as a teratogen. Semin Perinatol. 2025 Jun;49(4):152083. doi: 10.1016/j.semperi.2025.152083. Epub 2025 Apr 11. PMID: 40216573.  
  • Jewett A, Memarzadeh S, Kaur K. Commentary: Ovarian Cancer: Path to Effective Treatments. Crit Rev Immunol. 2025;45(1):93-99.doi:10.1615/CritRevImmunol.2024053766. PMID: 39612280  
  • Koch MR, Rimal P, Echeverria G, Robrahn M, Sridhar A. The world of contraception: A global mapping project across FIGO member societies. Int J Gynecol Obstet. 2025; 00: 1-9. doi:10.1002/ijgo.70254  
  • Huerta-Yepez S, Chen PC, Kaur K, Jain Y, Singh T, Esedebe F, Liao YJ, DiBernardo G, Moatamed NA, Mei A, Malarkannan S, Graeber TG, Memarzadeh S, Jewett A. Supercharged NK Cells, Unlike Primary Activated NK Cells, Effectively Target Ovarian Cancer Cells Irrespective of MHC-Class I Expression. BMJ Oncol. 2025 Apr 5;4(1):e000618. doi: 10.1136/bmjonc-2024-000618. PMID: 40196236  
  • Kim TH, Memarzadeh S, Vahdatshariatpanahi S, Ostrzega N, Kang Y, Moatamed NA. Significance of Androgen Receptor and Its Potential for Anti-Androgen/Androgen Receptor-Antagonist Therapy in Ovarian Cancers. PLOS ONE. 2025 Mar 20. Available at: https://doi.org/10.1371/journal.pone.0322744  
  • Jimenez NR, Herman CR, Łaniewski P, Cope E, Lee K, Mahnert ND, Chase DM, Caporaso JG, Herbst-Kralovetz MM. Navigating Complexities of Polymorphic Microbiomes in Endometrial Cancer. NPJ Biofilms Microbiomes. 2025 May 22;11(1):85. doi: 10.1038/s41522-025-00690-1. PMID: 40404643; PMCID: PMC12098703  
  • Recouvreux MS, Orsulic S. Before They Were Malignant. Cancer Discov. 2025 Jun 3;15(6):1093-1095. doi: 10.1158/2159-8290.CD-25-0429.PMID: 40457835  
  • Schab A, Compadre A, Drexler R, Loeb M, Rodriguez K, Brill J, Harrington S, Sandoval C, Sanders B, Kuroki L, McCourt C, Hagemann AR, Thaker P, Mutch D, Powell M, Serra V, Hagemann IS, Walts AE, Karlan BY, Orsulic S, et al. Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer. MM. J Clin Invest. 2025 May 20:e189511. doi: 10.1172/JCI189511. Online ahead of print.PMID: 40392598   
  • Aggarwal A, Jana M, Singh A, Dam T, Maurya H, Pathak T, Orsulic S, Yang K, Chute D, Bishop JA, Faraji F, Thorstad WM, Koyfman S, Steward S, Shi Q, Sandulache V, Saba NF, Lewis JS Jr, Corredor G, Madabhushi A. Artificial intelligence-based virtual staining platform for identifying tumor-associated macrophages from hematoxylin and eosin-stained images.  
  • Eur J Cancer. 2025 May 2;220:115390. doi: 10.1016/j.ejca.2025.115390. Epub 2025 Mar 26.PMID: 40158294  
  • Jewett A, Memarzadeh S, Kaur K. Commentary: Ovarian Cancer: Path to Effective Treatments. Crit Rev Immunol. 2025;45(1):93-99. doi: 10.1615/CritRevImmunol.2024053766. PMID: 39612280  
  • Sara Huerta-Yepez, Po-Chun Chen, Kawaljit Kaur, Yash Jain, Tanya Singh, Favour Esedebe, Yi Jou Liao, Gabriella DiBernardo, Neda A Moatamed, Ao Mei, Subramaniam Malarkannan, Thomas G Graeber, Sanaz Memarzadeh, Anahid Jewett. Supercharged NK cells, unlike primary activated NK cells, effectively target ovarian cancer cells irrespective of MHC-class I expression. BMJ Oncol. 2025 Apr 5;4(1):e000618. doi: 10.1136/bmjonc-2024-000618. PMID: 40196236  
  • Lo L, Erica Manrriquez E, Holschneider M, Pineda E, Russo J, Mae Zakhour M, Holschneider CH. Attitudes toward telehealth visits among Spanish-and English-speaking patients in a safety-net gynecologic oncology clinic. Telemed J E Health. 2025 Mar 24. doi: 10.1089/tmj.2024.0582. Online ahead of print. PMID: 40129042  
  • Duzyj CM, Einerson BD, Afshar Y, Fox KA, Saad AF, Carusi DA, Herrera CL, Lyell DJ, Abuhamad AZ, Farber MK, Roberts AC, Hobson SR, Sentilhes L, Sibai BM, Matsuo K, Terlizzi K, Shainker SA, Silver RM, Bartels HC, Shipp TD, Huang M, Cahill AG, Wright JD, Saade GR, Longo M. Placenta Accreta Spectrum, Present and Future: The Eunice Kennedy Shriver National Institute of Child Health and Human Development Workshop Summary. Obstet Gynecol. 2025 May 1. doi: 10.1097/AOG.0000000000005929. Epub ahead of print. PMID: 40311146.   
  • Tang J, Ligumsky LK, Woodruff K, Jang C, Charland N, Al Haj Baddar N, Ahmed E, Van Hummelen P, Heilek G, Zimmermann B, Bunnapradist S, Tabriziani H, Afshar Y. A Novel Method to Estimate Donor-Derived Cell-Free DNA in Pregnant Kidney Transplant Recipients: A Proof-of-Concept Study. Transplant Proc. 2025 Apr 28:S0041-1345(25)00226-X. doi: 10.1016/j.transproceed.2025.03.025. Epub ahead of print. PMID: 40300906.   
  • Afshar Y, Kashani Ligumsky L, Bartels HC, Krakow D. Biology and Pathophysiology of Placenta Accreta Spectrum Disorder. Obstet Gynecol. 2025 Apr 10. doi: 10.1097/AOG.0000000000005903. Epub ahead of print. PMID: 40209229.   
  • Kirschner V, Yin O, Coscia L, Diala PC, Shahandeh N, Irani RA, Constantinescu S, Moritz MJ, Afshar Y. Heart Transplant and Pregnancy: Evaluating the Role of Preeclampsia in Maternal, Neonatal, and Graft Morbidity. JACC Heart Fail. 2025 Mar;13(3):498-507. doi: 10.1016/j.jchf.2024.11.016. PMID: 40044385.   
  • Kashani-Ligumsky L, Scott O, Martinez G, Jeong A, Yin O, Shah S, Wang A, Zhu Y, Afshar Y. Updates and Knowledge Gaps in Placenta Accreta Spectrum Biology. Clin Obstet Gynecol. 2025 Apr 21. doi: 10.1097/GRF.0000000000000929. Epub ahead of print. PMID: 40257851.  
  • Duzyj CM, Einerson BD, Afshar Y, Fox KA, Saad AF, Carusi DA, Herrera CL, Lyell DJ, Abuhamad AZ, Farber MK, Roberts AC, Hobson SR, Sentilhes L, Sibai BM, Matsuo K, Terlizzi K, Shainker SA, Silver RM, Bartels HC, Shipp TD, Huang M, Cahill AG, Wright JD, Saade GR, Longo M. Placenta Accreta Spectrum, Present and Future: The Eunice Kennedy Shriver National Institute of Child Health and Human Development Workshop Summary. Obstet Gynecol. 2025 May 1. doi: 10.1097/AOG.0000000000005929. Epub ahead of print. PMID: 40311146.  
  • Bosakova M, Abraham SP, Wachtell D, Zieba JT, Kot A, Nita A, Czyrek AA, Koudelka A, Ursachi VC, Feketova Z, Rico-Llanos G, Svozilova K, Kocerova P, Fafilek B, Gregor T, Kotaskova J, Duran I, Vanhara P, Doubek M, Mayer J, Soucek K, Krakow D, Krejci P. Endoplasmic reticulum stress disrupts signaling via altered processing of transmembrane receptors. Cell Commun Signal. 2025 Apr 30;23(1):209. doi: 10.1186/s12964-025-02208-w. PMID: 40307870; PMCID: PMC12044870.  
  • Safi LA, Al-Safi ZA. Fertility counseling for patients with hereditary breast and ovarian cancer syndrome. Curr Opin Obstet Gynecol. 2025 Apr 30. doi: 10.1097/GCO.0000000000001038. Epub ahead of print. PMID: 40304291.  
  • Tang J, Ligumsky LK, Woodruff K, Jang C, Charland N, Al Haj Baddar N, Ahmed E, Van Hummelen P, Heilek G, Zimmermann B, Bunnapradist S, Tabriziani H, Afshar Y. A Novel Method to Estimate Donor-Derived Cell-Free DNA in Pregnant Kidney Transplant Recipients: A Proof-of-Concept Study. Transplant Proc. 2025 Apr 28:S0041-1345(25)00226-X. doi: 10.1016/j.transproceed.2025.03.025. Epub ahead of print. PMID: 40300906.  
  • Rasouli MA, Katz J, Dumesic DA. Interface between reproductive and metabolic dysfunction in polycystic ovary syndrome. Curr Opin Obstet Gynecol. 2025 Apr 29. doi: 10.1097/GCO.0000000000001037. Epub ahead of print. PMID: 40299715.  
  • Iyer NS, Patel V, Roman A, Clarfield L, Contag S, Menzies R, Berghella V. Cerclage Reinforcement Following Primary Cerclage Procedure for Prevention of Preterm Birth: A Systematic Review and Meta-Analysis. BJOG. 2025 Apr 29. doi: 10.1111/1471-0528.18185. Epub ahead of print. PMID: 40297973.  
  • Secord AA, Bae-Jump V, Backes F, Thaker P, Gehrig PA, Previs RA, Borden L, Thomas SM, Jackson A, Konecny GE, Duska LR, Arend R, Wright J, Corr B, Maxwell GL, Cosgrove CM, Mullen MM, Washington C, Herzog TJ, Cohen J, Hou J, Gaillard S, Fader AN, Berchuck A, Pothuri B. Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort study. Int J Gynecol Cancer. 2025 Apr 7;35(5):101758. doi: 10.1016/j.ijgc.2025.101758. Epub ahead of print. PMID: 40288096.  
  • Pangelina C, Bergman J, Cheng T, Fantus R, Galvez A, Gin G, Grisales T, Koola J, Lukacz ES, Millen M, Moore A, Okamuro K, Reuben D, Santiago-Lastra Y, Singer J, Suarez M, Tai-Seale M, Vaida F, Souders C, Anger J. OUTPACE: Outcomes of urinary incontinence treatment in primary care - APP co-management and electronic consult. Contemp Clin Trials. 2025 Apr 21;153:107922. doi: 10.1016/j.cct.2025.107922. Epub ahead of print. PMID: 40268237.  
  • Fajardo-Martinez V, Ferreira F, Fuller T, Cambou MC, Kerin T, Paiola S, Mok T, Rao R, Mohole J, Paravastu R, Zhang D, Marschik P, Iyer S, Kesavan K, Borges Lopes MDC, Britto JAA, Moreira ME, Brasil P, Nielsen-Saines K. Neurodevelopmental delay in children exposed to maternal SARS-CoV-2 in-utero. Sci Rep. 2024 May 24;14(1):11851. doi: 10.1038/s41598-024-61918-2. PMID: 38789553; PMCID: PMC11126599.  
  • Salani R, et al.  A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04).  Int J Gynecol Cancer. 2024 Aug;34(8):1140-1148. doi: 10.1136/ijgc-2024-005588. Epub 2024 Dec 10.  
  • Ruegg L, James-Allan LB, DiBernardo G, Ochoa C, Li YR, Yang L, Memarzadeh S. An Efficient Method for Extracting Human Fallopian Tube Epithelia for Single-cell Analyses. J Vis Exp. 2025 Mar 28;(217). doi: 10.3791/67753.  
  • Huston-Paterson HH, Mora V, Karlan BY, Teshome M. Medicaid Coverage of NCCN- and ASCO/SSO-Guideline-Concordant BRCA Germline Testing for Patients with Breast Cancer: Opportunity to Embrace Rapid Advancements in Precision Medicine. Ann Surg Oncol. 2025 Feb;32(2):646-649. doi: 10.1245/s10434-024-16306-5. Epub 2024 Nov 23. PMID: 39580377.  
  • Phillips KA, Kotsopoulos J, Domchek SM, Terry MB, Chamberlain JA, Bassett JK, Aeilts AM, Andrulis IL, Buys SS, Cui W, Daly MB, Eisen AF, Foulkes WD, Friedlander ML, Gronwald J, Hopper JL, John EM, Karlan BY, Kim RH, Kurian AW, Lubinski J, Metcalfe K, Nathanson KL, Singer CF, Southey MC, Symecko H, Tung N, Narod SA, Milne RL; Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2. J Clin Oncol. 2025 Feb;43(4):422-431. doi: 10.1200/JCO.24.00176. Epub 2024 Oct 2. PMID: 39356978; PMCID: PMC11771360.  
  • Diet, Polycyclic Aromatic Hydrocarbons, and Oxidative Stress Biomarkers in Pregnancy: a Los Angeles Pregnancy Cohort. Yu KE, Mitra S, Meng Q, DelRosario I, Devaskar SU, Janzen C, Sullivan PS, Chen L, Jerrett M, Ritz B. Environ Res. 2025 Mar 13:121399. doi: 10.1016/j.envres.2025.121399. Online ahead of print. PMID: 40088999  
  • Pregnancy After Solid Organ Transplantation: Review of the Evidence and Recommendations. Katz-Greenberg G, Afshar Y, Bonn J, Casale J, Constantinescu S, DeFilippis EM, George RP, Iltis A, Jesudason S, Kittleson M, Levine DJ, Moritz MJ, Sarkar M, Shah S, Uccellini K, Coscia LA, Rossi AP; American Society of Transplantation Women’s Health Community of Practice Reproductive Health, Contraception and Pregnancy after Transplantation and Living Donation Controversies Conference Participants. Transplantation. 2025 Mar 13. doi: 10.1097/TP.0000000000005341. Online ahead of print. PMID: 40074722  
  • Transvaginal Electrical Stimulation for Treatment of Overactive Bladder Without Incontinence: A Pilot Cross-Over Clinical Trial. Torosis M, Stothers L, Cisneros C, Dominique G, Ackerman, AL. Neurourol Urodyn. 2025 Mar 26. doi: 10.1002/nau.70034. PMID: 40135809  
  • Attitudes Toward Telehealth Visits Among Spanish- and English-Speaking Patients in a Safety-Net Gynecological Oncology Clinic. Lo L, Manrriquez E, Holschneider MP, Pineda E, Russo J, Zakhour M, Holschneider C. Telemed J E Health. 2025 Mar 24. doi: 10.1089/tmj.2024.0582. PMID: 40129042   
  • Biology, care, and outcomes of gestational breast cancers: a review. Diggirala N, Zhang S, Master A, Rao R, Kapoor N, Bardia A, Breast Cancer Res Treat. 2025 Mar 28. doi: 10.1007/s10549-025-07684-9. PMID: 40155574  
  • Comprehensive Sexuality Education, Healthcare Professional Associations, and the Future of the World’s Youth. Nicola J. Gray, C.P. Bansal, Esther Corona, Yasmin Jayasinghe, Melissa Kang, Marisa Labovsky, Aparna Sridhar, Linda Sussman, Jonathan D. Klein, Journal of Adolescent Health, 2025. doi:10.1016/j.jadohealth.2025.02.002.  
  • ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for early-stage cervical cancer. Leitao MM Jr, Bixel KL, Chase DM, Quick A, McCormick C, Black D, Lim PC, Eskander RN, Gotlieb WH, LoCoco S, Martino MA, Walker JL, Copeland LJ, Monk BJ, Randall LM. Int J Gynecol Cancer. 2025 Feb 28:101760. doi: 10.1016/j.ijgc.2025.101760. PMID: 40188007.  
  • Protocol to profile tumor and microenvironment from ovarian cancer patient samples and evaluate cell-based therapy using in vitro killing assays. Li YR, Ochoa CJ, Lyu Z, Zhu Y, Chen Y, DiBernardo G, Ruegg L, Memarzadeh S, Yang L. STAR Protoc. 2025 Apr 5;6(2):103742. doi: 10.1016/j.xpro.2025.103742. Epub ahead of print. PMID: 40188433.  
  • Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial. Van Gorp T, Moore KN, Konecny GE, Leary A, García-García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Caruso G, Klasa-Mazurkiewicz D, Tromp J, Martin LP, Breuer S, Leath CA 3rd, Cibula D, Weroha SJ, Estévez-García P, O'Malley DM, Miller RE, Coffman L, Scandurra G, Berton D, Li L, Zagadailov E, Diver EJ, Trédan O, Hilpert F. Lancet Oncol. 2025 Apr;26(4):503-515. doi: 10.1016/S1470-2045(25)00021-X. PMID: 40179908.  
  • Associations between brominated flame retardants, including polybrominated diphenyl ethers, and immune responses among women in the California Teachers Study. Cauble EL, Reynolds P, Epeldegui M, Dassanayake PS, Magpantay L, Blyakher D, Regmi P, Von Behren J, Martinez-Maza O, Goldberg D, Spielfogel ES, Lacey JV Jr, Wang SS.  Front Epidemiol. 2025 Mar 19;5:1452934. doi: 10.3389/fepid.2025.1452934. PMID: 40177061; PMCID: PMC11962006.  
  • Ozturk H, Seker-Polat F, Abbaszadeh N, Kingham Y, Orsulic S, Adli M.  High PRMT5 levels, maintained by KEAP1 inhibition, drive chemoresistance in high-grade serous ovarian cancer. J Clin Invest. 2025 Mar 17;135(6):e184283.  
  • Yu KE, Mitra S, Meng Q, DelRosario I, Devaskar SU, Janzen C, Sullivan PS, Chen L, Jerrett M, Ritz B.  Diet, Polycyclic Aromatic Hydrocarbons, and Oxidative Stress Biomarkers in Pregnancy: a Los Angeles Pregnancy Cohort. Environ Res. 2025 Mar 13:121399. doi: 10.1016/j.envres.2025.121399. Online ahead of print. PMID: 40088999  
  • Katz-Greenberg G, Afshar Y, Bonn J, Casale J, Constantinescu S, DeFilippis EM, George RP, Iltis A, Jesudason S, Kittleson M, Levine DJ, Moritz MJ, Sarkar M, Shah S, Uccellini K, Coscia LA, Rossi AP; American Society of Transplantation Women’s Health Community of Practice Reproductive Health, Contraception and Pregnancy after Transplantation and Living Donation Controversies Conference Participants Pregnancy After Solid Organ Transplantation: Review of the Evidence and Recommendations. Transplantation. 2025 Mar 13. doi: 10.1097/TP.0000000000005341. Online ahead of print. PMID: 40074722  
  • Kirschner V, Yin O, Coscia L, Diala PC, Shahandeh N, Irani RA, Constantinescu S, Moritz MJ, Afshar Y. Heart Transplant and Pregnancy: Evaluating the Role of Preeclampsia in Maternal, Neonatal, and Graft Morbidity. JACC Heart Fail. 2025 Mar;13(3):498-507. doi: 10.1016/j.jchf.2024.11.016. PMID: 40044385.  
  • Riley G, Wang E, Flynn C, Lopez A, Sridhar A. Evaluating the fidelity of AI-generated information on long-acting reversible contraceptive methods. Eur J Contracept Reprod Health Care. 2025 Feb 6:1-4. doi: 10.1080/13625187.2025.2450011. Epub ahead of print. PMID: 39912404.  
  • Woofter R, Patil R, Sudhinaraset M, Gipson J. Long-acting reversible contraceptive preference and initiation among clinic-based and telemedicine medication abortion patients at one academic health system in California. Contraception. 2025 Feb 10:110838. doi: 10.1016/j.contraception.2025.110838. Epub ahead of print. PMID: 39938673.